Comprehensive cancer genome sequencing studies have shown that most cancers contain a small number of frequently mutated well-known oncogenes and tumor suppressors (such as p53 and PIK3CA), alongside a larger pool of less frequent, unique mutations. This evidence concerns the gene PIK3CA and neoplasm.